Introducing a pneumococcal vaccine to an existing influenza immunization program: Vaccination rates and predictors of noncompliance

被引:47
作者
Opstelten, W [1 ]
Hak, E [1 ]
Verheij, TJM [1 ]
van Essen, GA [1 ]
机构
[1] Univ Utrecht, Med Ctr, Julius Ctr Gen Practice & Patient Oriented Res, NL-3508 AB Utrecht, Netherlands
关键词
D O I
10.1016/S0002-9343(01)00880-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: Influenza vaccination has been recommended for all elderly people in The Netherlands since 1996, with greater than 80% compliance. It is unknown, however, if the addition of another vaccine to this immunization program will affect compliance. SUBJECTS AND METHODS: General practitioners offered a pneumococcal vaccine together with the yearly influenza vaccination to 3365 patients aged 65 years and older. A questionnaire was then mailed to a stratified sample (n = 972) of these patients. Factors associated with noncompliance with vaccination were assessed using polytomous logistic regression. RESULTS: A total of 2529 patients (75%) received the pneumococcal vaccine and 2812 (84%) received the influenza vaccine. Predictors of noncompliance with the pneumococcal vaccine were perceived lack of recommendation by the general practitioner (odds ratio [OR] = 4.6; 95% confidence interval [CI], 2.6 to 8.3) and fear of local side effects (OR = 2.8; 95% CI, 1.6 to 4.6). Predictors of noncompliance with both vaccinations also included unwillingness to comply with the doctor's advice (OR = 6.1; 95% Cl, 2.4 to 15.4), the belief that vaccinations weaken one's natural defenses (OR = 2.7; 95% Cl, 1.4 to 5.3) or that influenza is not dangerous (OR = 2.9; 95% Cl, 1.5 to 5.4), and the fear of becoming sick from pneumococcal vaccination (OR = 2.9; 95% Cl, 1.1 to 7.9). People who felt healthy found it difficult to visit the doctor's office, had private medical insurance, or were younger than 75 years of age also had a greater risk of not being vaccinated. CONCLUSION: Introducing a pneumococcal vaccine to an existing influenza immunization program resulted in high pneumococcal and influenza vaccination rates. A wider diversity of patient characteristics and attitudes was present when neither vaccination was received. (C) 2001 by Excerpta Medica, Inc.
引用
收藏
页码:474 / 479
页数:6
相关论文
共 27 条
  • [1] BROOME CV, 1981, REV INFECT DIS, V3, pS82
  • [2] Influenza and pneumococcal vaccination among Native American elders in a primary care practice
    Buchwald, D
    Sheffield, J
    Furman, R
    Hartman, S
    Dudden, M
    Manson, S
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (10) : 1443 - 1448
  • [3] PNEUMOCOCCAL POLYSACCHARIDE VACCINE EFFICACY - AN EVALUATION OF CURRENT RECOMMENDATIONS
    BUTLER, JC
    BREIMAN, RF
    CAMPBELL, JF
    LIPMAN, HB
    BROOME, CV
    FACKLAM, RR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (15): : 1826 - 1831
  • [4] *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P86
  • [5] Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P657
  • [6] PREVENTING PNEUMOCOCCAL BACTEREMIA IN PATIENTS AT RISK - RESULTS OF A MATCHED CASE-CONTROL STUDY
    FARR, BM
    JOHNSTON, BL
    COBB, DK
    FISCH, MJ
    GERMANSON, TP
    ADAL, KA
    ANGLIM, AM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (21) : 2336 - 2340
  • [7] Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease
    Fletcher, TJ
    Tunnicliffe, WS
    Hammond, K
    Roberts, K
    Ayres, JG
    [J]. BRITISH MEDICAL JOURNAL, 1997, 314 (7095) : 1663 - 1665
  • [8] *GEZ, 1982, ADV INZ PNEUM IMM
  • [9] Pneumococcal vaccination of the elderly: Do we need another trial?
    Hak, E
    Grobbee, DE
    van Essen, GA
    Buskens, E
    Verheij, TJM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (11) : 1698 - 1699
  • [10] Hak E, 2000, SCAND J PRIM HEALTH, V18, P237